Voya Investment Management LLC Relmada Therapeutics, Inc. Transaction History

Voya Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.17 - $35.84 $20,799 - $343,526	-9,585 Reduced 47.13%	10,752 $37,000
Q3 2022 Mar 03, 2023	BUY	$18.3 - $37.02 $175,405 - $354,836	9,585 Added 89.15%	20,337 $752,000
Q3 2022 Nov 14, 2022	BUY	$18.3 - $37.02 $183,823 - $371,865	10,045 Added 97.6%	20,337 $753,000
Q2 2022 Aug 15, 2022	BUY	$16.5 - $30.34 $169,818 - $312,259	10,292 New	10,292 $195,000
Q2 2021 Aug 16, 2021	SELL	$29.55 - $39.15 $208,741 - $276,555	-7,064 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$31.52 - $39.28 $222,657 - $277,473	7,064 New	7,064 $249,000
Q3 2020 Nov 16, 2020	SELL	$34.42 - $43.78 $168,141 - $213,865	-4,885 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$31.59 - $49.98 $154,317 - $244,152	4,885 New	4,885 $219,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.9M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.